Enovix (NASDAQ:ENVX – Get Free Report) is expected to be issuing its Q2 2026 results after the market closes on Wednesday, August 12th. Analysts expect the company to post earnings of ($0.14) per share and revenue of $8.4310 million for the quarter. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. Individuals may review the information on the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Wednesday, August 12, 2026 at 5:00 PM ET.
Enovix (NASDAQ:ENVX – Get Free Report) last announced its quarterly earnings data on Wednesday, May 13th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.15) by $0.01. The business had revenue of $7.60 million during the quarter, compared to the consensus estimate of $6.95 million. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.Enovix’s revenue for the quarter was up 49.1% on a year-over-year basis. During the same period in the prior year, the company earned ($0.15) EPS. On average, analysts expect Enovix to post $-1 EPS for the current fiscal year and $-1 EPS for the next fiscal year.
Enovix Price Performance
Shares of NASDAQ ENVX opened at $4.70 on Monday. The company has a market cap of $1.03 billion, a price-to-earnings ratio of -5.66 and a beta of 2.32. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14. Enovix has a 12 month low of $3.67 and a 12 month high of $14.21. The stock has a 50-day moving average price of $5.69 and a two-hundred day moving average price of $5.96.
Institutional Trading of Enovix
Analyst Ratings Changes
A number of research firms recently issued reports on ENVX. Benchmark lowered their price objective on shares of Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a research report on Thursday, May 14th. Craig Hallum lowered their price target on shares of Enovix from $10.00 to $8.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Oppenheimer reduced their price objective on Enovix from $24.00 to $21.00 and set an “outperform” rating on the stock in a research report on Thursday, May 14th. Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a report on Saturday, May 16th. Finally, JPMorgan Chase & Co. lowered Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Six investment analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $12.50.
Check Out Our Latest Stock Analysis on ENVX
About Enovix
Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.
Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.
Read More
- Five stocks we like better than Enovix
- Albemarle’s Blowout Quarter Shows Why Lithium Still Matters
- Can DICK’S Turn Foot Locker Into a Winner?
- Why Dutch Bros Plunged Despite a Q2 Earnings Beat and Record Revenue
- Take-Two’s Q1 Results Leave GTA 6 Bulls Stuck in the Fog of War
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
